John D. Halpern serves as Executive at Eterna Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, John D. Halpern has executed 1 insider transactions totaling $1.1M, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 2, 2022 involved purchasing 335,920 shares valued at $1.1M.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Dec 2, 2022 | ERNA | $1.1M | Purchase | 335,920 | $3.28 | Discretionary |
John D. Halpern currently holds 450,961 shares of Eterna Therapeutics Inc. (ERNA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John D. Halpern has been a net buyer of ERNA stock. They have purchased $1.1M and sold $0 worth of shares.
John D. Halpern's most recent insider trade was on Dec 2, 2022, when they purchased 335,920 shares at $3.28 per share.
Get notified when new Form 4 filings are submitted